Item

MMI0022 (MMI0022)

Non-Food Product
Locations
Location name Address
KD Pharma Group 14193 SW 119 Avenue Miami, FL 33186
Documents
Type Location File name Effective Expiration
Product Specification Sheet KD Pharma Group BSE MMI0022_001.pdf 10/21/2021 10/20/2024
BSE - TSE KD Pharma Group BSE MMI0022_001.pdf 10/27/2021 10/26/2024
California Prop. 65 KD Pharma Group CA Prop65 MMI0022_001.pdf 10/27/2021 10/27/2023
CoA Sample KD Pharma Group COA MMI0022.pdf 11/16/2021 11/16/2023
Irradiation Status Statement KD Pharma Group ETO Irradiation Statemen_001.pdf 10/27/2021 10/27/2023
EtO Statement KD Pharma Group ETO Irradiation Statemen_001.pdf 10/27/2021 10/27/2023
GMO KD Pharma Group GMO MMI0022_001.pdf 10/27/2021 10/27/2023
GRAS/NDI/ODI Statement KD Pharma Group GRAS MMI0022_001.pdf 10/27/2021 10/26/2024
HACCP Process Flow Diagram KD Pharma Group HACCP Flow Chart.pdf 10/27/2021 10/27/2023
Halal KD Pharma Group Halal MMI0022_001.pdf 10/27/2021 10/27/2024
Heavy Metal KD Pharma Group HeavyMetal MMI0022_001.pdf 10/27/2021 10/27/2023
Kosher KD Pharma Group Kosher MMI0022_001.pdf 10/27/2021 10/27/2024
Natural KD Pharma Group Natural MMI0022_001.pdf 10/27/2021 10/27/2022
No Animal Ingredient Statement KD Pharma Group NonAnimal MMI0022_001.pdf 10/27/2021 10/27/2022
Organic KD Pharma Group Organic MMI0022_001.pdf 10/27/2021 10/27/2024
Pesticide KD Pharma Group Pesticides MMI0022_001.pdf 10/27/2021 10/27/2023
Phthalate Esters Letter KD Pharma Group Phthalate MMI0022_001.pdf 10/27/2021 10/27/2022
Residual Statement KD Pharma Group ResSolv MMI0022_001.pdf 10/27/2021 10/27/2022
Safety Data Sheet (SDS) KD Pharma Group SDS MMI0022_001.pdf 10/27/2021 10/26/2024